CA
DTIL icon

CHI Advisors’s Precision BioSciences DTIL Stock Holding History

CHI Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-333
Closed -$8K – 24
2020
Q4 		$8K Buy
+333
New +$81.6K ﹤0.01% 22

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CHI Advisors's DTIL Position: Q3 2023 in Review

CHI Advisors reduced its Precision BioSciences (DTIL) stake by 62% in Q3 2023, selling an estimated $511K and leaving 20,221 shares worth $207K. The position accounts for 0.08% of the portfolio, ranked #26.

CHI Advisors first reported a position in DTIL in Q3 2019 and has held it in 17 quarters since. The position peaked at $12.3M in Q4 2019. 76 funds tracked by Wall St. Rank hold DTIL as of Q3 2023.

  • CHI Advisors held 20,221 shares of Precision BioSciences worth $207K as of Q3 2023.
  • CHI Advisors sold 33,231 Precision BioSciences shares in Q3 2023, an estimated $511K.
  • Precision BioSciences made up 0.08% of CHI Advisors's portfolio in Q3 2023, its #26 holding.
  • CHI Advisors first reported a position in Precision BioSciences in Q3 2019 and has held it in 17 quarters since.
  • CHI Advisors's Precision BioSciences position peaked at $12.3M in Q4 2019.
  • 76 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2023.

Based on CHI Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.